US 7541035
Immunogenic peptides for the treatment of prostate and breast cancer
granted A61KA61K2039/53A61K2039/57
Quick answer
US patent 7541035 (Immunogenic peptides for the treatment of prostate and breast cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/53, A61K2039/57, A61K2239/49, A61K2239/58